Health Coaching Strategies for Preventing Postpartum Diabetes
(STRIVE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study coordinator or your healthcare provider.
What data supports the effectiveness of this treatment for preventing postpartum diabetes?
Research shows that the Group Lifestyle Balance (GLB) program, an adaptation of the Diabetes Prevention Program (DPP), is effective in reducing the risk of type 2 diabetes. Health coaching, a key component of this treatment, has been successfully integrated into primary care for diabetes management, suggesting its potential effectiveness in preventing postpartum diabetes.12345
Is the Diabetes Prevention Program safe for humans?
The Diabetes Prevention Program (DPP) and its adaptations, like the Group Lifestyle Balance program, have been widely studied and implemented in various settings, including technology-assisted formats and even in prisons. These studies focus on lifestyle changes and have not reported any significant safety concerns, suggesting that the program is generally safe for humans.12678
How does the treatment for preventing postpartum diabetes differ from other treatments?
This treatment is unique because it combines in-person and technology-assisted health coaching to deliver the Diabetes Prevention Program (DPP) specifically adapted for postpartum women, focusing on lifestyle changes to reduce diabetes risk. Unlike standard treatments, it emphasizes personalized support and engagement through health coaching, which is not commonly used in traditional diabetes prevention strategies.910111213
What is the purpose of this trial?
The primary objective of the STRIVE study is to compare two implementation strategies for Diabetes Prevention Program delivery: an in-person health coach strategy (standard 24 in-person sessions at WIC clinics) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person sessions at WIC clinics supplemented by technology support) on implementation and health-related outcomes in postpartum women.
Eligibility Criteria
This trial is for postpartum women who are 18 or older, gave birth within the last year, and have obesity or a history of gestational diabetes. They should not currently have diabetes (except gestational), plan to become pregnant soon, or move away in the next year. Access to a smartphone is required.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 24 in-person health coaching sessions or 12 in-person sessions with technology support over one year
Follow-up
Participants are monitored for sustainability of the implementation strategies 6 months after the intervention
Treatment Details
Interventions
- In-person health coach delivery of the GLB
- Technology-assisted health coach delivery of the GLB
In-person health coach delivery of the GLB is already approved in United States for the following indications:
- Type 2 diabetes prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
Pennington Biomedical Research Center
Collaborator
University of Pennsylvania
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator